Effect of norethindrone acetate in the treatment of symptomatic endometriosis

International Journal of Fertility and Women's Medicine

Volumn 43, Issue 1, 1998, Pages 24-27

  Muneyyirci Delale, O ^a   Karacan, M ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Endometriosis; Norethindrone acetate

Indexed keywords

CONJUGATED ESTROGEN; NORETHISTERONE ACETATE;

ADULT; ARTICLE; BREAKTHROUGH BLEEDING; BREAST DISEASE; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG EFFICACY; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; FEMALE; HUMAN; LAPAROSCOPY; MAJOR CLINICAL STUDY; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; ENDOMETRIOSIS; FEMALE; HUMANS; NORETHINDRONE; PATIENT DROPOUTS; PROGESTERONE CONGENERS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE HEMORRHAGE;

EID: 0031908286     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kistner RW: The treatment of endometriosis inducing pseudopregnancy with ovarian hormones. Fertil Steril 10:539, 1959.
2. Hornstein E, Barbieri RL: Endocrine therapy of endometriosis, in Barbieri RL, Schiff I (eds): Reproductive Endocrine Therapeutics. New York, Alan R. Liss, p. 175, 1988.
3. Riva HL, Wilson JH, Kawasaki DM: Effect of norethynodrel on endometriosis. Am J Obstet Gynecol 82:109, 1963.
4. Riva HL, Kawasaki DM, Messinger AJ: Further experience with norethynodrel in treatment of endometriosis. Obstet Gynecol 19:111, 1962.
5. Dlugi AM, Miller JD, Knittle J, Lupron Study Group: Lupron Depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Fertil Steril 54:419, 1990.
6. Timonen S, Johansson CJ: Endometriosis treated with lynestrenol. Ann Chir Gynecol Fenn 57:144, 1968.
7. Johnston WI: Dydrogesterone and endometriosis. Br J Obstet Gynaecol 83:77, 1976.
8. Moghissi KS, Boyce CR: Management of endometriosis with oral medroxyprogesterone acetate. Obstet Gynecol 47:265, 1976.
9. Greenblatt RB, Tzingounis V: Danazol treatment of endometriosis: long-term follow-up. Fertil Steril 32:518, 1979.
10. Barbieri RL, Evans S, Kistner RW: Danazol in the treatment of endometriosis: analysis of 100 cases with a 4 year follow-up. Fertil Steril 37:737, 1982.
11. Schenken RS, Malinak LR: Reoperation after treatment of endometriosis with conservative surgery. Am J Obstet Gynecol 131:426, 1978.
12. Lebherz TB, Fobes CO: Management of endometriosis with nor-progesterone. Am J Obstet Gynecol 81:102, 1961.
13. Ottoson UB, Johansson BG, von Schoultz B: Subfraction of high density lipoprotein cholesterol during estrogen replacement therapy: A comparison between progestogens and natural progesterone. Am J Obstet Gynecol 151:74, 1985.
14. Wynn V, Niththyananthan R: The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. Am J Obstet Gynecol 142:766, 1981.
15. Whitehead MI, Townsend PT, Pryse-Davies J, et al: Effects of various types and dosages of progestogens on the postmenopausal endometrium. J Reprod Med 27:539, 1982.
16. Buttram VC, Jr, Belvue JB, Reiter R: Interim report of a study of danazol for the treatment of endometriosis. Fertil Steril 37:478, 1982.
17. Jelley RY, Magill PJ: The effect of LHRH agonist therapy in the treatment of endometriosis (English Experience), in Barbieri RL, Schiff I (eds): Gonadotropin Down-Regulation in Gynecological Practice. New York, Alan R. Liss, p. 227, 1986.
18. Henzl MR, Corson SL, Moghissi K, et al: Administration of nasal Nafarelin as compared with oral Danazol for endometriosis: A multicenter double-blind comparative clinical trial. N Engl J Med 318:485, 1988.
19. Dawood MY, Lewis V, Ramos J: Cortical and trabecular bone mineral content in women with endometriosis: Effect of gonadotropin-releasing hormone agonist and danazol. Fertil Steril 52:21, 1989.
20. Surrey ES, Gambone JC, Lu JK, et al: The effects of combining norethistrone with a gonadotropin releasing hormone agonist in the treatment of symptomatic endometriosis. Fertil Steril 53:629, 1990.
21. Surrey ES, Judd HL: Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. J Clin Endocrin Met 75(2):558, 1992.
22. Horowitz M, Wishort J, Need AG, et al: Treatment of postmenopausal hyperparathyroidism with norethindrone. Arch Intern Med 147:681, 1987.
23. Abdalla HI, Hort DM, Lindsay R, et al: Prevention of bone mineral loss in postmenopausal women by norethistrone. Obstet Gynecol 66:789, 1985.
24. DeCherney A: Physiologic and pharmacologic effects of estrogen and progestin on bone. J Reprod Med 38:1007, 1993.